openPR Logo
Press release

Huateng Pharma Supplies Anti-diabetic API Intermediates With Huge Stock

Huateng Pharma Supplies Anti-diabetic API Intermediates With

Diabetes is a serious chronic disease characterized by elevated blood sugar concentrations associated with the effects of abnormal beta cell biology on insulin action. Diabetes occurs when the pancreas does not produce enough insulin or the body does not use the insulin it does produce efficiently.

The most common forms of diabetes are type 1 diabetes and type 2 diabetes. Type 1 diabetes is characterized by insufficient insulin production and the need for daily insulin intakes, and it is unclear what causes it. More than 95 percent of people with diabetes have type 2 diabetes, which is characterized by the body's abnormal use of insulin that affects the body's use of glucose for energy, mainly due to obesity, physical inactivity and genetics.

Type 1 diabetes is treated with insulin injections. The majority of diabetic patients are obesity-induced patients, that is, type 2 diabetes patients. Type 2 diabetes mainly uses hypoglycemic drugs to control blood sugar, and often requires life-long medication, such as metformin, sulfonylureas, or sodium-glucose cotransporter type 2 (SGLT-2) inhibitors, etc. If the islet function is reduced or insulin secretion is too low, insulin injection therapy also needs to be considered. Non-drug-assisted treatment of type 2 diabetes is mainly diet control and exercise. Most type 2 diabetes is caused by obesity. Obese people have abnormal fat distribution and excessive accumulation, which will lead to insulin resistance and overload the pancreas. Weight loss can be used to regulate lipid metabolism, thereby affecting glucose metabolism, and repairing lipid metabolism to achieve the goal of balancing glucose metabolism.

For ordinary people, if you want to prevent diabetes, you must first monitor your blood sugar and have regular physical examinations; in addition, you must maintain a healthy diet, reduce your sugar intake, and eat more low-glycemic foods (mainly coarse grains and other foods), work and rest, and do some aerobic exercise appropriately; of course, the most important thing is to maintain a healthy weight, and eliminating obesity is the most effective measure to treat and prevent diabetes.

Huateng Pharma is a professional pharmaceutical intermediates supplier. It can provide anti-diabetic drugs intermediates such as semaglutide intermediates, canagliflozin intermediates, dapagliflozin intermediates, empagliflozin intermediates for customers' research. Huateng Pharma has its own factory and make scale-up production with capacities varying from gram to kilograms and multi tons.

Canagliflozin Intermediates:
(5-Bromo-2-methylphenyl)[5-(4-fluorophenyl)-2-thienyl]methanone
CAS NO.1132832-75-7
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
CAS NO.898566-17-1
2-[(5-bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene
CAS NO.1030825-20-7
2-(4-Fluorophenyl)thiophene
CAS NO.58861-48-6
2-Methyl-5-bromobenzoic acid
CAS NO.79669-49-1

Semaglutide Intermediates:
CH2COOH-PEG2-NH2.HCl
CAS NO.: 134979-01-4
Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH
CAS NO.1662688-20-1
Boc-NH-PEG2-CH2COOH
CAS NO.: 108466-89-3
NH2-PEG2-CH2COOH
CAS NO.: 134978-97-5
Octadecanedioic acid
CAS NO.871-70-5

Dapagliflozin Intermediates:
4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzene
CAS NO.1103738-29-9
Benzene, 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]-
CAS NO.461432-23-5

Empagliflozin Intermediates:
(3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane
CAS NO.915095-89-5
(S)-4-iodo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene
CAS NO.915095-94-2

Hunan Huateng Pharmaceutical Co. Ltd.
Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China
Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China
Email: sales@huatengusa.com
Website: https://us.huatengsci.com
Zip code: 410205
Telephone: +86 731 89916275
Fax: +86 0731-82251112-818

Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Huateng Pharma Supplies Anti-diabetic API Intermediates With Huge Stock here

News-ID: 3148497 • Views:

More Releases from Hunan Huateng Pharmaceutical Co. Ltd.

Huateng Pharma Supplies Minoxidil Intermediate 2,4-Diamino-6-chloropyrimidine (CAS NO.156-83-2)
Huateng Pharma Supplies Minoxidil Intermediate 2,4-Diamino-6-chloropyrimidine (C …
Minoxidil was first introduced by Upjohn Company of the United States, and was first used as an oral drug for the treatment of refractory hypertension in the 1970s. In later clinical applications, doctors observed hair regrowth and generalized excessive hair in balding patients, which led to the development of minoxidil preparations. Minoxidil can increase local blood supply, stimulate the proliferation and differentiation of hair follicle epithelial cells, so as to promote
Huateng Pharma Supplies Some Intermediates of CDK4/6 Inhibitors for Treatment of Advanced Breast Cancer
Huateng Pharma Supplies Some Intermediates of CDK4/6 Inhibitors for Treatment of …
Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and also causes the greatest number of cancer-related deaths among women. In 2018, it is estimated that 627,000 women died from breast cancer - that is approximately 15% of all cancer deaths among women. While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally. The majority
ADC Drugs For HER2 Positive Breast Cancer
ADC Drugs For HER2 Positive Breast Cancer
According to the latest data, breast cancer has overtaken lung cancer to become the most common cancer among women, and the death rate is the second highest among female tumors, seriously affecting the physical and mental health of women around the world. Patients with abnormal expression of human epidermal growth factor receptor (HER2) account for 15%-20% of all breast cancers, which is highly invasive and has poor prognosis. Although more drug
TPD Show Potential For The Treatment of Alzheimer's Disease
TPD Show Potential For The Treatment of Alzheimer's Disease
Targeted protein degradation (TPD) is a promising strategy in the field of drug discovery. In recent years, targeted protein degradation (TPD) technology has developed rapidly, especially proteolysis targeting chimera (PROTAC), which is the most representative technology of TPD strategy. TPD drugs are one of the hot spots of new drug development in recent years, especially in the field of oncology. For example, a TPD drug developed by Arvinas has achieved

All 5 Releases


More Releases for CAS

Top Factor Driving Cas Nuclease Market Growth in 2025: Increasing Biotech Invest …
How Big Is the Cas Nuclease Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been a quick escalation in the size of the cas nuclease market. The market valuation is projected to increase from $3.27 billion in 2024 to $3.89 billion in 2025, while maintaining a compound annual growth rate (CAGR) of 19.2%. This significant growth during the historical period can be traced
Altimedia Achieves Widevine CAS 3PL Partnership
Image: https://www.abnewswire.com/uploads/1671b7044637885642f07dbf55abb228.jpg Global digital media total solutions company Altimedia named a certified 3PL (Third Party Lab) partner for its Widevine CAS solution, AltiProtect-WCAS. This partnership underscores Altimedia's reliability and technical expertise in the global digital content protection solutions market. AltiProtect-WCAS, originated from the source technology of Widevine, is a conditional access solution that helps PayTV service providers prevent illegal copying and unauthorized access. With this new 3PL partnership, it's verified Altimedia offers
Visit CAS DataLoggers at WEFTEC 2022
Ernest N. Morial Convention Center, October 8 - 12, New Orleans, LA CAS DataLoggers is proud to announce that we will be exhibiting at the WEFTEC 2022 Conference! Hosted at the Morial Convention Center in New Orleans, LA on October 8-12, WEFTEC 2022 will bring together water professionals from around the world in person and virtually! This year, CAS DataLoggers President Peter Martin is attending along with CAS DataLoggers Engineering Manager
Visit CAS DataLoggers at Pittcon 2020
The World's Largest Lab Expo, March 3rd-5th in Chicago CAS DataLoggers is proud to announce that we will be exhibiting along with TandD US, LLC at Pittcon 2020! Pittcon is the world's leading annual conference and exposition on laboratory science. Hosted in Chicago, IL at McCormick Place on March 3rd-5th, Pittcon 2020 will draw a large crowd of attendees from industry, academia, and government from over 90 countries! This year, CAS
Visit CAS DataLoggers at AHR 2020
The World’s Largest HVAC event is about to get underway—the annual AHR 2020 Expo is returning to Orlando, FL on Feb 3-5th. CAS DataLoggers Sales Mgr. Peter Martin is proud to attend along with Japan’s #1 datalogger manufacturer—T&D! Come visit us at Booth #7490 to see our cutting-edge HVAC solutions for performance validation, energy audits, and more! With prices starting at just $109, T&D products give businesses and organizations an affordable
CRISPR & CRISPR-associated (Cas) Genes Market to 2027 - Global Analysis and Fore …
CRISPR and CRISPR-Associated (Cas) Genes is a genome editing tool that enables the researchers to make changes in the DNA. CRISPR-Cas9 stands for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9. In recent years the CRISPR and CRISPR-Associated (Cas) Genes has gained lot of popularity as it offers it is cheaper, faster, accurate, and more efficient genome editing methods. The CRISPR and CRISPR-associated (Cas) Genes market is anticipated to